Kit for detecting epidermal growth factor receptor (EGFR) mutation by primer specific fluorescence polymerase chain reaction (PCR)

A kit and a specific technology, applied in the determination/inspection of microorganisms, biochemical equipment and methods, etc., can solve the problems of difficult to guarantee the probe sequence, high price, and increased detection cost of multiple probes, and achieve fast detection speed, Avoid pollution and facilitate clinical operation

Active Publication Date: 2009-10-28
DAAN GENE CO LTD
View PDF0 Cites 32 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, on the one hand, the design of Taqman-MGB probes has strict requirements on the template sequence, and it is difficult to ensure that there are suitable probe sequences at all mutation positions; on the other hand, using the specificity of Taqman probes to detect mutations requires specific Design a pai

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Kit for detecting epidermal growth factor receptor (EGFR) mutation by primer specific fluorescence polymerase chain reaction (PCR)
  • Kit for detecting epidermal growth factor receptor (EGFR) mutation by primer specific fluorescence polymerase chain reaction (PCR)
  • Kit for detecting epidermal growth factor receptor (EGFR) mutation by primer specific fluorescence polymerase chain reaction (PCR)

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0052] Embodiment 1: EGFR gene mutation detection kit and its use

[0053] (1) Composition of the kit

[0054] 1 tube of PCR reaction solution A (820 μl / tube), 1 tube of PCR reaction solution B (820 μl / tube), 1 tube of PCR reaction solution C (820 μl / tube), 1 tube of enzyme system (240 μl / tube), wild-type quality control 1 tube of product (30ul / tube), 1 tube of 19 mutant standard product (30μl / tube), 1 tube of 19 mutant standard product (30μl / tube), 1 tube of negative control (30μl / tube). PCR reaction solution A includes 19-type forward primer, 19 wild-type reverse primer, 19-type fluorescent probe, PCR buffer, purified water; PCR reaction solution B includes 19-type forward primer, 19 mutant 1-7 reverse primer Direction primer, 19-type fluorescent probe, PCR buffer, purified water; PCR reaction solution C includes 21-type forward primer, 21 mutant reverse primer, 21-type fluorescent probe, PCR buffer, purified water; Taq enzyme The system includes UNG enzymes, dNTPs, Taq en...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a kit for detecting the epidermal growth factor receptor (EGFR) mutation by a primer specific fluorescence polymerase chain reaction (PCR), in particular to the diagnosis of the EGFR gene mutation in tumor tissues and peripheral blood serums of tumor patients. Aiming at specific mutant sites relative to the curative effects of molecular targeted anti-cancer drugs, the kit is provided with a specific oligonucleotide primer sequence and a probe sequence, carries out fluorescence PCR detection respectively through a wild type PCR system and a mutation type PCR system on each sample to be detected and judges whether the samples have the mutation of EGFR19 exons and 21 exons or not through the magnitude of a difference value (delta Ct) of Ct values of two times of reaction. The kit can detect whether the specific sites of the EDFR have the mutation or not and can be used for the curative effect forecast of new molecular targeted anti-cancer drugs and the guidance of clinical individualized medicine application programs of the tumor patients.

Description

technical field [0001] The invention relates to a real-time fluorescent PCR detection kit, in particular to a kit for detecting common mutations of epidermal growth factor receptor (Epithelium Growth Factor Recptor, EGFR) by primer-specific real-time quantitative fluorescent PCR technology. Background technique [0002] Gefitinib (gefitinib, Iressa) EGFR tyrosine kinase inhibitor (EGFR-TKI), developed by AstraZeneca, is a new type of tumor-targeted therapy drug that effectively cuts off the epidermal growth factor receptor Send a signal into the cell, thereby hindering the development of tumors. Studies by scholars in the United States, Japan, and China in recent years have shown that somatic mutations of EGFR are associated with sensitivity to gefitinib in NSCLC patients. For tumors with EGFR mutations, the effective rate of Gefitinib is as high as 80%-90%, but for most tumors without EGFR mutations, Gefitinib has no effect. The EGFR protein tyrosine kinase functional reg...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12Q1/68
Inventor 吴荃李明程钢何蕴韶
Owner DAAN GENE CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products